搜索临床试验以:贝伐珠单抗、曲贝替定和卡铂
总计5257个结果
-
National Cancer Institute (NCI)主动,不招人复发性输卵管癌 | 复发性卵巢癌 | 复发性原发性腹膜癌 | IV 期输卵管癌 AJCC v6 和 v7 | IV 期卵巢癌 AJCC v6 和 v7 | IV 期原发性腹膜癌 AJCC v7 | 卵巢高级别浆液性腺癌 | 铂敏感性卵巢癌 | 转移性卵巢癌 | 转移性输卵管癌 | 转移性原发性腹膜癌 | 卵巢子宫内膜样瘤美国
-
National Cancer Institute (NCI)NRG Oncology完全的复发性输卵管癌 | 复发性卵巢癌 | 复发性原发性腹膜癌 | 卵巢透明细胞囊腺癌 | 卵巢子宫内膜样腺癌 | 卵巢浆液性癌 | 卵巢浆液性囊腺癌 | 卵巢透明细胞腺癌 | 卵巢粘液腺癌 | 输卵管移行细胞癌 | 卵巢移行细胞癌 | 输卵管透明细胞腺癌 | 输卵管子宫内膜样腺癌 | 输卵管粘液腺癌 | 输卵管浆液性腺癌 | 卵巢浆液性腺癌 | 卵巢布伦纳瘤 | 卵巢粘液性囊腺癌 | 未分化卵巢癌 | 未分化输卵管癌美国
-
Jiangsu HengRui Medicine Co., Ltd.完全的
-
Dutch Society of Physicians for Pulmonology and...完全的
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical Center; Genentech, Inc.; Brigham and...完全的卵巢癌 | 输卵管癌 | 原发性腹膜癌 | 乳头状浆液性苗勒管肿瘤 | 透明细胞苗勒管瘤美国
-
UNC Lineberger Comprehensive Cancer CenterNational Cancer Institute (NCI)完全的
-
National Cancer Institute (NCI)完全的
-
Swiss Group for Clinical Cancer Research完全的
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)完全的
-
University of Medicine and Dentistry of New JerseyNational Cancer Institute (NCI)终止
-
Genentech, Inc.完全的
-
Gruppo Oncologico Italia Meridionale未知Non-squamous Nonsmall Cell Neoplasm of Lung意大利
-
Janssen Research & Development, LLC不再可用
-
Virginia Commonwealth UniversityNational Cancer Institute (NCI)撤销IIIA期非小细胞肺癌 | IIIB 期非小细胞肺癌 | 鳞状细胞肺癌 | 肺腺癌 | 大细胞肺癌 | IIA期非小细胞肺癌 | IIB 期非小细胞肺癌
-
Fondazione Policlinico Universitario Agostino Gemelli...完全的
-
European Organisation for Research and Treatment...PharmaMar终止
-
UNC Lineberger Comprehensive Cancer CenterEli Lilly and Company; Genentech, Inc.完全的
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)完全的
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New Jersey完全的
-
National Cancer Institute (NCI)终止IIIA期非小细胞肺癌 | IIIB 期非小细胞肺癌 | II期非小细胞肺癌 | 肺腺癌 | 支气管肺泡细胞肺癌 | 大细胞肺癌美国
-
European Organisation for Research and Treatment...Sarcoma Alliance for Research through Collaboration终止
-
Leiden UniversityCancer Research UK; NCIC Clinical Trials Group; Mario Negri Institute for Pharmacological Research 和其他合作者主动,不招人
-
National Cancer Institute (NCI)终止
-
Massachusetts General HospitalDana-Farber Cancer Institute; Genentech, Inc.; Celgene Corporation完全的
-
Johnson & Johnson Pharmaceutical Research & Development...PharmaMar完全的
-
Kosei Hasegawa, MD, PhD招聘中
-
National Cancer Institute (NCI)招聘中肛管泄殖腔癌 | 转移性肛门鳞状细胞癌 | 复发性肛门鳞状细胞癌 | III 期肛门癌 AJCC v8 | IV 期肛门癌 AJCC v8 | 不可切除的肛门鳞状细胞癌 | 肛门基底样鳞状细胞癌美国
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)完全的
-
M.D. Anderson Cancer Center主动,不招人三阴性乳腺癌 | I 期乳腺癌 AJCC v7 | IA 期乳腺癌 AJCC v7 | IB 期乳腺癌 AJCC v7 | II 期乳腺癌 AJCC v6 和 v7 | IIA 期乳腺癌 AJCC v6 和 v7 | IIB 期乳腺癌 AJCC v6 和 v7 | III 期乳腺癌 AJCC v7 | IIIA 期乳腺癌 AJCC v7 | IIIB 期乳腺癌 AJCC v7 | IIIC 期乳腺癌 AJCC v7美国
-
AGO Research GmbHARCAGY/ GINECO GROUP; Australia New Zealand Gynaecological Oncology Group; Arbeitsgemeinschaft... 和其他合作者完全的
-
Sun Yat-sen UniversityShenzhen People's Hospital; Sixth Affiliated Hospital, Sun Yat-sen University; Dongguan People... 和其他合作者尚未招聘
-
Intensity Therapeutics, Inc.Premier Research Group plc尚未招聘
-
Catholic University of the Sacred Heart未知
-
Genentech, Inc.完全的非鳞状非小细胞肺癌西班牙, 法国, 美国, 台湾, 英国, 菲律宾, 拉脱维亚, 意大利, 以色列, 阿根廷, 墨西哥, 德国, 马来西亚